No Benefit of Levothyroxine in Heart Donors

New data challenge the common practice of levothyroxine administration in potential heart donors after brain death to preserve heart function and make more hearts available for transplantation.

Related Keywords

California ,United States ,Stanford University ,Missouri ,Washington University ,Raj Dhar ,Kiran Khush ,Stanford University School Of Medicine ,Washington University School Of Medicine ,Washington University School ,Thenew England Journal ,Major Implications ,Stanford University School ,Cardiomyopathy ,Heart Failure ,Transplantation Heart ,Cardiac Transplantation ,Ransplantation Cardiac ,Heart Transplantation ,Heart ,Cardiovascular Imaging ,Ardiac Imaging ,V Imaging ,Transplantation ,Transplant ,Transplantation Organ ,Organ Transplantation ,Brain Death ,Brain ,Organ Procurement And Transplantation Network ,Ptn Organ Procurement And Transplantation Network ,Nited Network For O ,